Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Advances in Electrophysiology Europe, 2013 – A Spotlight on Ion Channel Research – Highlighting Automated Physiology

10 Dec 2013 - 10 Dec 2013 - Saffron Walden, Cambridge, UK



Bookmark and Share


Advances in drug discovery technologies now allow ion channels to be significantly more promising targets for drug discovery. This meeting has been structured to focus on recent developments in patch clamp, which have revolutionised the use of electrophysiology as a tool for drug discovery and functional screening. An authoritative panel of experienced pharmaceutical industry scientists and academics has been assembled for this meeting that will have a special emphasis upon automated electrophysiology.

Professor David Brown, UCL, UK and Dr Edward Stevens, Pfizer Neusentis, UK will give the keynote presentations. Professor David Brown will discuss his far-reaching research into the regulation of ion channels that control neural excitability, with a special emphasis on his work with the Kv7 potassium channel. Drawing upon his extensive knowledge of the drug discovery industry both in CRO’s and pharmaceutical companies, Dr Edward Stevens will review the contribution that automated electrophysiology is making to drug discovery and development.

Speakers will then discuss the development and potential of these new technologies, present experimental results obtained with these systems and debate the potential impact of current technologies and future developments.

These presentations will include data from platforms including the IonWorks Barracuda®, IonWorks® Quattro™, PatchXpress® and IonFlux™ instrumentation:

  • Matthew Bridgland-Taylor, AstraZeneca, UK - Exploitation of the IonWorks Barracuda Automated Electrophysiology Platform to Improve Assessment of Cardiac Liability
  • Kelly Gatfield, GlaxoSmithKline, UK - Development of IonWorks Barracuda assays for use in early stage safety profiling
  • Gary Clarke, BioFocus DPI, UK - Ion Channel Drug Discovery: Case Study Utilising Automated Electrophysiology
  • Mark McPate, Novartis, UK - Investigation of the TRPC Channel using the IonWorks Quattro
  • Oliver Leven, GeneData, Switzerland - Genedata Screener for Automated Patch Clamping



Further information
Scientific News
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Microalgae Make a Splash in the UK Cosmeceutical Market
Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market.
Mechanism of Tumor Suppressing Gene Uncovered
The most commonly mutated gene in cancer,p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
Useful Colon Cancer Biomarker Discovered
Biomarker is detectable with simple, inexpensive test.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Seeing Hope
Gene therapy/drug combo restores some vision in mice with optic nerve injury.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!